You just read:

Eisai Inc. Announces Positive Topline Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Outcome Trial for the Anti-Obesity Agent BELVIQ®

News provided by

Eisai Inc.

Jul 17, 2018, 09:00 ET